(secondQuint)Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer.

 OBJECTIVES: Primary Objectives: 1.

 To preliminarily test the efficacy of fluoxetine to improve the quality of life of patients with advanced non-small cell lung cancer receiving chemotherapy by decreasing anxiety, depression and fatigue.

 2.

 To test the feasibility of conducting a multi-center clinical trial of fluoxetine administered by oncologists concurrently with chemotherapy in patients with non-small cell lung cancer.

 Secondary Objectives: 1.

 To describe the tumor response rate associated with the administration of gemcitabine/cisplatin in patients with advanced non-small cell lung cancer.

 2.

 To describe the overall survival and failure-free survival associated with the administration of gemcitabine/cisplatin.

 3.

 To describe the toxicity associated with the administration of gemcitabine/cisplatin.

.

 Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer@highlight

This trial is designed to test the efficacy of fluoxetine to improve patient's quality of life during chemotherapy.

 An innovative application of a selective serotonin reuptake inhibitor may modulate the effects of fatigue, anxiety and depression which worsen quality of life.

